Archived slides were reviewed using light microscopy in all cases.
Results. The study group consisted of 7 patients with primary PVS and 4 patients with PVS after TAPVC repair. Diagnosis of PVS was established by two-dimensional and Doppler echocardiographic studies of each pulmonary vein. Computed tomography (CT) was performed in 9 of 11 patients (except 2 patients with primary PVS) to provide better assessment of the PV upstream. In patients with primary PVS, affected pulmonary veins were diffusely stenotic, with stenosis extending into the lung parenchyma, i.e. "upstream" stenosis [11] . Among these patients, bilateral disease was present in 4 cases. Also, patients with primary PVS were characterized by progressively worsening obstruction. We observed a patient who died within one month after primary PVS repair: autopsy showed that all PVs became occluded along their length even after successful surgical relief confirmed at discharge.
In post-surgical group the extent of stenosis was mostly limited to the ostial segment of pulmonary veins.
Histological findings. Macroscopically, specimens consisted of pulmonary vein wall fragments adjacent to the left atrium, fibrous tissue from the vein lumen and occasional complete cross-sections. Microscopically, abnormal intimal proliferation and duplication of inner elastic membrane were identified, which led to the lumen obstruction in Abstract. Pulmonary vein stenosis (PVS) is a rare but serious condition characterized by obstruction of extrapulmonary segments of pulmonary veins which leads to progressive pulmonary hypertension.
Objective. In this study we aimed to determine relationship between clinical features and histopathologic findings in patients with PVS. Material and methods. We retrospectively reviewed 34 consecutive patients who underwent PV stenosis repair. Surgical wedge biopsy specimens were collected intraoperatively in 11 patients and reviewed using light microscopy.
Results. Affected pulmonary veins in patients with primary PVS were characterized by diffuse stenosis extending into the lung parenchyma. In post-surgical group stenosis was found in a limited segment of pulmonary vein at its ostium. Microscopically, abnormal intimal proliferation was identified in both patient groups. Scaring was predominant finding in patients with post-surgical PVS.
Conclusion.
In patients with PVS, pathophysiological mechanism influences the severity and extent of clinical manifestations. A comprehensive understanding of this mechanism may improve results of the treatment.
Keywords: pulmonary vein stenosis, pulmonary hypertension, total anomalous pulmonary venous connection, intimal proliferation.
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вроджені вади серця stenotic pulmonary veins ( Fig. 1 ) in both groups of patients. Meanwhile, in specimens obtained from post-surgical patients, scaring was predominant finding. Typical fibromyxoid intimal thickening was absent in only one specimen obtained from post-surgical patient. Heavily collagenized scarring at the site of direct veno-atrial anastomosis (Fig. 2) caused luminal obstruction in this case. This patient subsequently underwent a series of repeated balloon angioplasties described previously [12] . Discussion. We studied and compared clinical features and histopathologic findings in patients with PVS. We found that patients with primary PVS are characterized by diffuse stenosis of pulmonary veins extending to the vessels of intraparenchymal segment, while in post-surgical group stenosis was mostly limited to an ostial segment of pulmonary vein. Microscopical examination revealed that specimens obtained from the patients from both primary and postsurgical PVS group had fibromyxoid intimal thickening, typical for this lesion, although in post-surgical PVS scaring was predominant finding. Thus, we identified correlation between clinical manifestation and histological findings in patients with PVS.
Surgical repair or transcatheter intervention is the main current therapeutic strategy, with results being, however, quite disappointing. The novel treatment should be targeted at pathophysiological mechanism. Ongoing medical treatment research is aimed at different pathogenetic mechanisms of PVS [9] . Callahan et al. [10] , Kato H et al. [11] have shown that activation of tyrosine kinase and angiotensin II pathways leads to PVS. Currently, there are 3 registered clinical trials related to PVS treatment. In two trials tyrosine-kinase pathway was targeted using known chemotherapeutic agents. The third trial studies losartan as an agent to reduce neointimal formation by blocking TGF-B and angiotensin II mediated endothelial to mesenchymal transition.
In our study we have identified typical histological findings characteristic for each of PVS subtypes. They reflect pathogenetic mechanism and influence further outcomes such as mortality and recurrence rates. Firbointimal proliferation is the main cause of disease progression and recurrence of PVS.
Conclusion. Certain pathophysiological mechanisms have been shown to influence the severity of clinical manifestation in different types of PVS. A comprehensive understanding of these mechanisms may improve results of the treatment. fig. 1 
